Vericel Corp. (VCEL)
38.38
+1.08
(+2.90%)
USD |
NASDAQ |
Dec 09, 16:00
38.34
-0.04
(-0.10%)
After-Hours: 07:48
Vericel EPS Diluted (Quarterly): 0.0978 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1489 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Veracyte, Inc. | 0.2401 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.074M |
| Revenue (Quarterly) | 67.50M |
| Total Expenses (Quarterly) | 62.43M |
| Enterprise Value | 1.905B |
| Gross Profit Margin (Quarterly) | 73.46% |
| Profit Margin (Quarterly) | 7.52% |
| Earnings Yield | 0.63% |
| Operating Earnings Yield | 0.36% |
| Normalized Earnings Yield | 0.6277 |